PMV Pharmaceuticals CEO David Mack's 2023 pay falls 38% to $2.2M
PMV Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 24, 2024
PMV Pharmaceuticals reported fiscal year 2023 executive compensation information on April 24, 2024.
In 2023, three executives at PMV Pharmaceuticals received on average a compensation package of $1.5M, a 42% decrease compared to previous year.
Average pay of disclosed executives at PMV Pharmaceuticals
David H. Mack, Chief Executive Officer, received $2.2M in total, which decreased by 38% compared to 2022. 60% of Mack's compensation, or $1.3M, was in option awards. Mack also received $295K in non-equity incentive plan and $586K in salary.
Winston Kung, Chief Financial Officer, received a compensation package of $1.3M, which decreased by 29% compared to previous year. 48% of the compensation package, or $604K, was in option awards.
Deepika Jalota, Chief Development Officer, earned $1.1M in 2023.
Related executives
You may also like
Source: SEC filing on April 24, 2024.